1. Glycyrrhizin functionalized CuS Nanoprobes for NIR Light-based therapeutic mitigation of acne vulgaris.
- Author
-
Ganeshan S, Parihar N, Chonzom D, Mohanakrishnan D, Das R, Sarma D, Gogoi D, Das MR, Upadhayula SM, and Pemmaraju DB
- Subjects
- Animals, Anti-Inflammatory Agents administration & dosage, Anti-Inflammatory Agents chemistry, Mice, Humans, Microbial Sensitivity Tests, Acne Vulgaris therapy, Glycyrrhizic Acid chemistry, Glycyrrhizic Acid administration & dosage, Glycyrrhizic Acid therapeutic use, Copper chemistry, Copper administration & dosage, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents chemistry, Nanoparticles chemistry, Nanoparticles administration & dosage, Infrared Rays, Propionibacterium acnes drug effects
- Abstract
Acne Vulgaris or Acne is a multifactorial bacterial infection caused by Propionibacterium acne, leading to inflammation and decreased quality of life, especially in adolescence. Currently, antibiotics and retinoids are preferred for treating acne. However, their continuous usage may lead to anti-microbial resistance and other side effects. Therefore, research on developing effective strategies to reduce antimicrobial resistance and improve acne healing is ongoing. The current work reports the synthesis and evaluation of near-infrared light-absorbing copper sulfide (CuS) nanoparticles loaded with a biomolecule, Glycyrrhizin (Ga). The photothermal efficacy studies, and in-vitro and in-vivo experiments indicated that the Ga-CuS NPs generated localized hyperthermia in acne-causing bacteria, leading to their complete growth inhibition. The results indicated that the Ga-Cus NPs possess excellent antibacterial and anti-inflammatory properties in the acne and inflammatory models. This could be from the synergistic effect of CuS NPs mediated mild Photothermal effect and inherent pharmacological properties of Ga. Further detailed studies of the formulations can pave the way for application in cosmetic clinics for the effective and minimally invasive management of Acne-like conditions., (© 2024. Controlled Release Society.)
- Published
- 2024
- Full Text
- View/download PDF